Expression of cytokeratin 19 in cytologic specimens of thyroid
โ Scribed by Mitsuyoshi Hirokawa; Aya Inagaki; Hirohisa Kobayashi; Takuo Kanahara; Toshiaki Manabe; Hiroshi Sonoo
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 17 KB
- Volume
- 22
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
โฆ Synopsis
Cytokeratin 19 is the lowest molecular weight cytokeratin and is found in a diverse range of normal epithelia and tumors. 1 On histologic sections, cytokeratin 19 has been expressed in all tumor cells of thyroid papillary carcinomas, but it has been absent or only focally present in follicular neoplasms and adenomatous goiters. 2-5 However, on cytologic smears there have been no reports concerning the expression of cytokeratin 19. Therefore, we investigated whether immunocytochemical staining using the anticytokeratin 19 antibody in cytologic smears is helpful in distinguishing among papillary carcinoma, adenomatous goiter, and follicular neoplasms of the thyroid.
From the files of the Cytology Laboratory, Kawasaki Medical School Hospital, we collected alcohol-fixed, Papanicolaou-stained smears imprinted from surgically resected thyroid lesions collected between January 1992-December 1997, which included 22 papillary carcinomas, 24 adenomatous goiters, 8 follicular adenomas, and 2 follicular carcinomas. The diagnoses of all cases were confirmed by histologic examination. Two cases of follicular carcinoma were of widely invasive type and revealed metastasis to the bone. After the smears were destained by ethyl alcohol, they were immunocytochemically stained using anti-cytokeratin 19 antibody (1:200, Progen, Heidelberg, Germany) and ENVISION reagent (Dako Japan, Kyoto, Japan). Negative controls were obtained by replacing the primary antibody with Tris-buffered saline. We used paraffin sections of papillary carcinoma as positive controls. The degree of immunoreaction was rated on a five-point scale: -, no staining; ฯฉ, 10% or less of cells have positive staining; 2ฯฉ, between 10-50% of cells have positive staining; 3ฯฉ, between 50-90% of cells have positive staining; and 4ฯฉ, 90% or more have positive staining.
Most cases of papillary carcinoma were strongly immunopositive for cytokeratin 19 (Table I). The staining pattern was predominantly pancytoplasmic. Central areas of the large clusters tended to be weakly positive or negative. The immunoreactivity for cytokeratin 19 was stronger in large tumor cells with abundant cytoplasm than in small tumor cells. Most follicular epithelial cells in adenomatous goiter
๐ SIMILAR VOLUMES
A series of 33 tumor cases (13 fine-needle aspirates and 20 effusion specimens) were evaluated for the expression of two cytokeratin (CK) subtypes; CK 20, expressed primarily in tumors of the GI tract, mucinous ovarian tumors and transitional cell carcinomas, and CK 7, found chiefly in non-GI tract
## BACKGROUND. Of the 20 known cytokeratins, CK-19 is expressed in normal urothel-Ami Klein, Ph
## Resection of Hepatic and Pulmonary Metastases in Patients with Colorectal Carcinoma W e read with interest the article by Ambiru et al. 1 concerning the resection of colorectal hepatic and pulmonary metastases. In a population of 156 patients with resected hepatic metastases from colorectal car
The present study was designed to clarify the mechanism by which some lung cancer cell lines can produce cytokeratin 19 (CK19) fragment and others cannot. We hypothesized that some lung cancer cell lines which cannot release CK19 express an incomplete sequence of CK19 mRNA. Expression of mRNA was ev